Literature DB >> 23993189

HPV vaccination programme in Japan.

Stuart Gilmour, Mikiko Kanda, Eiji Kusumi, Tetsuya Tanimoto, Masahiro Kami, Kenji Shibuya.   

Abstract

Mesh：

Substances：

Year:  2013        PMID： 23993189     DOI： 10.1016/S0140-6736(13)61831-0

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  32 in total

1.  Compensation programs after withdrawal of the recommendation for HPV vaccine in Japan.

Authors:  Koichiro Yuji; Haruka Nakada
Journal:  Hum Vaccin Immunother       Date:  2015-10-29       Impact factor: 3.452

Review 2.  A review of factors affecting vaccine preventable disease in Japan.

Authors:  Norimitsu Kuwabara; Michael S L Ching
Journal:  Hawaii J Med Public Health       Date:  2014-12

3.  Mothers' preferences regarding new combination vaccines for their children in Japan, 2014.

Authors:  Aiko Shono; Masahide Kondo
Journal:  Hum Vaccin Immunother       Date:  2016-12-01       Impact factor: 3.452

4.  Human papillomavirus (HPV) awareness and vaccine receptivity among Senegalese adolescents.

Authors:  Philip M Massey; Ruth K Boansi; Jessica D Gipson; Rachel M Adams; Helene Riess; Thierno Dieng; Michael L Prelip; Deborah C Glik
Journal:  Trop Med Int Health       Date:  2016-11-14       Impact factor: 2.622

5.  Improved parental attitudes and beliefs through stepwise perinatal vaccination education.

Authors:  Aya Saitoh; Akihiko Saitoh; Isamu Sato; Tomohiro Shinozaki; Hajime Kamiya; Satoko Nagata
Journal:  Hum Vaccin Immunother       Date:  2017-08-30       Impact factor: 3.452

6.  Effect on HPV vaccination in Japan resulting from news report of adverse events and suspension of governmental recommendation for HPV vaccination.

Authors:  Akiko Morimoto; Yutaka Ueda; Tomomi Egawa-Takata; Asami Yagi; Yoshito Terai; Masahide Ohmichi; Tomoyuki Ichimura; Toshiyuki Sumi; Hiromi Murata; Hideharu Kanzaki; Hidekatsu Nakai; Masaki Mandai; Kiyoshi Yoshino; Masami Fujita; Tadashi Kimura; Junko Saito; Tomotaka Sobue; Nobumichi Nishikawa; Masayuki Sekine; Takayuki Enomoto; Yorihiko Horikoshi; Tetsu Takagi
Journal:  Int J Clin Oncol       Date:  2014-07-09       Impact factor: 3.402

7.  Why is it appropriate to recommend human papillomavirus vaccination as cervical cancer prevention?

Authors:  Robert A Bednarczyk; Daniella Figueroa-Downing; Kevin Ault
Journal:  Am J Obstet Gynecol       Date:  2015-10-31       Impact factor: 8.661

8.  A Japanese survey of malignant disease in pregnancy.

Authors:  Yoshiyuki Kobayashi; Tsutomu Tabata; Mayu Omori; Eiji Kondo; Toru Hirata; Kenta Yoshida; Masayuki Sekine; Atsuo Itakura; Takayuki Enomoto; Tomoaki Ikeda
Journal:  Int J Clin Oncol       Date:  2018-10-27       Impact factor: 3.402

Review 9.  HPV vaccines: a controversial issue?

Authors:  A F Nicol; C V Andrade; F B Russomano; L L S Rodrigues; N S Oliveira; D W Provance
Journal:  Braz J Med Biol Res       Date:  2016-04-08       Impact factor: 2.590

10.  National genotype prevalence and age distribution of human papillomavirus from infection to cervical cancer in Japanese women: a systematic review and meta-analysis protocol.

Authors:  Matthew Palmer; Kota Katanoda; Eiko Saito; Cecilia Acuti Martellucci; Shiori Ostuki; Shuhei Nomura; Erika Ota; Julia M L Brotherton; Jane Hocking
Journal:  Syst Rev       Date:  2021-05-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.